Table 2.
Comparison of selected clinical-pathological characteristics and treatment characteristics in female and male elderly PTMC patients.
Variable | Males N=1,123(23.34%) |
Female N=3,689(76.76%) |
P value2 |
---|---|---|---|
Age at diagnosis | 0.790 | ||
(mean±standard deviation SD) | 71.15±5.13 | 71.20±5.50 | |
Race | 0.012 | ||
White | 973 (86.64) | 3,036 (83.03) | |
Black | 57 (5.08) | 259(7.02) | |
Other1 | 93 (8.28) | 367(9.95) | |
Marital status | <0.001 | ||
Married | 857 (76.31) | 1,960(53.13) | |
Unmarried | 210 (18.70) | 1,507(40.85) | |
Unknown | 56 (4.99) | 222(6.02) | |
Insurance status | 0.506 | ||
Insured | 874 (77.83) | 2,897(78.53) | |
Uninsured | 3 (0.27) | 18(0.49) | |
Unknown | 246 (21.90) | 774(20.98) | |
Surgery | 0.330 | ||
No surgery | 9 (0.80) | 20(0.54) | |
Lobectomy | 317 (28.22) | 1,001(27.13) | |
Total thyroidectomy | 796(70.88) | 2,667(72.30) | |
Unknown | 1 (0.10) | 1(0.03) | |
Radiotherapy | <0.001 | ||
Yes | 287 (25.56) | 743(20.14) | |
No | 828 (73.73) | 2,892(78.40) | |
Unknown | 8 (0.71) | 54(1.46) | |
TNM stage | <0.001 | ||
I-II | 914 (81.39) | 3,260(88.37) | |
III-IV | 178 (15.85) | 339(9.19) | |
Unknown | 31 (2.76) | 90(2.44) | |
T stage | 0.343 | ||
T1-T2 | 1,041 (92.70) | 3,463(93.87) | |
T3-T4 | 80 (7.12) | 222(6.02) | |
Tx | 2(0.18) | 4(0.11) | |
N stage | <0.001 | ||
N0 | 957(85.22) | 3,431(93.01) | |
N1 | 149(12.27) | 195(5.29) | |
Nx | 17(1.51) | 63(1.70) | |
M stage | 0.002 | ||
M0 | 1,099(97.86) | 3,638(98.62) | |
M1 | 12(1.07) | 10(0.27) | |
Mx | 12(1.07) | 41(1.11) | |
Grade | 0.036 | ||
Well differentiated | 164(14.60) | 529(14.34) | |
Moderately differentiated | 28(2.49) | 90(2.44) | |
Poorly differentiated | 5(0.45) | 7(0.19) | |
Undifferentiated | 4(0.36) | 1(0.03) | |
Unknown | 922(82.10) | 3062(83.00) |
PTMC, papillary thyroid microcarcinoma. TNM, tumor-node-metastasis.
1Includes American Indian/AK Native, Asian/Pacific Islander.
Tx, primary tumor cannot be assessed.
Nx, regional lymph nodes cannot be assessed.
Mx, distant metastasis cannot be assessed.
2Refers to comparison for the differences in proportions in female and male patients.